Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209499-05-000029
Filing Date
2005-02-10
Accepted
2005-02-10 16:55:50
Documents
2
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 5  
1 PRIMARY DOCUMENT edgardoc.xml 5 4686
2 EDGAR SUPPORTING DOCUMENT ullian2.txt EX-24 2979
  Complete submission text file 0001209499-05-000029.txt   9712
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Issuer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HOLOGIE INC 35 CROSBY DRIVE BEDFORD MA 01730
Business Address
ULLIAN ELAINE (Reporting) CIK: 0001190290 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-11397 | Film No.: 05593779